Related Tags >> Erbitux Deals Serono Mergers and Acquisitions

Merck KgAA News

Most Popular Merck KgAA Story

Big Pharma takes an interest in cancer vaccines

September 19, 2007 — 10:49am ET | By Maureen Martino

For two decades, biotech companies have struggled to develop therapeutic cancer vaccines designed to treat the disease by stimulating the immune system to attack cancer cells without harming normal... Read more...

Merck KgAA Press Releases

Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
Committee For Medicinal Products For Human Use Post-Authorisation Summary Of Positive Opinion For Erbitux
Merck KGaA Submits New License Application for Erbitux in Firstline Non-Small Cell Lung Cancer in Europe
PRESS RELEASE: Merck Initiates a New Phase III Clinical Trial of Safinamide in Early Parkinson’s Disease
PRESS RELEASE: ImClone and BMS Announce Joint Agreement with Merck KGaA to Co-Develop and Co-Commercialize ERBITUX in Japan

Latest Headlines

Analysts applaud positive MS data for Merck KGaA drug
April 30, 2009
Novartis, Merck KGaA spotlight new MS drugs
April 27, 2009
MS Society teams with Merck KGaA on $19M R&D pact
March 18, 2009
Ambrx, Merck KGaA ink MS development deal
February 24, 2009
Oncothyreon sells drug rights, cuts jobs
December 19, 2008
Merck Serono, Theratechnologies ink $215M deal
October 29, 2008
ZymoGenetics shares plunge after risks halt trial
October 28, 2008
Merck KGaA eyes ImClone, but isn't mystery bidder
October 1, 2008
Merck KGaA - Biotech Market Share Report
September 28, 2008
ALSO NOTED: New York pumps biotech complex; Investors focus on NZ biotech; Questions about anti-TNF safety;and much more...
June 5, 2008
ALSO NOTED: BioSeek to collaborate with Merck KGaA; BioAlliance acquires drug rights; and much more...
May 20, 2008
ALSO NOTED: U.S. hatches $265M regenerative medicine initiative; Merck KGaA budgets €1B for R&D;and much more...
April 22, 2008
Avastin, Erbitux battle for lung cancer market
April 21, 2008
ALSO NOTED: Ablynx pockets upfront fee; Plexxikon publishes cancer data; Solvay drug on fast track; and much more...
February 19, 2008
Idera shares surge on Merck KGaA pact
December 19, 2007
Merck KGaA starts Phase III Parkinson's trial
November 28, 2007
Big Pharma takes an interest in cancer vaccines
September 19, 2007
ALSO NOTED: Gates gives $280M to fight TB; Merck drug proves positive in Phase II;Merck KGaA exec eyes acquisitions;much more..
September 19, 2007
Erbitux clears late-stage hurdle for lung cancer
September 11, 2007
Matuzumab in doubt after trial failure
August 29, 2007

Paid Research Reports

More Research Reports >>